chartexchange

Mirum Pharmaceuticals (MIRM) Breaches Primary Endpoint in Phase 3 Hepatitis Delta Trial

GuruFocus | Nov 10, 2026 2:00 PM EST

Related Stocks: MIRM ,

Read original article